Framingham: 10-year cardiovascular risk
Adds the Framingham general score points and shows 10-year cardiovascular disease risk.
When to use
Adult without established cardiovascular disease, to estimate the risk of a first event over 10 years.
Pearls and pitfalls
- The score predicts total cardiovascular disease: coronary events, stroke, heart failure and intermittent claudication.
- Systolic pressure scores differently depending on antihypertensive treatment.
- Age points differ by sex: 45 years is 5 for women and 6 for men.
- The risk table runs from under 1% to over 30%, and the extremes are shown as a band rather than an exact number.
Fill in the fields to see the result.
Formula
Add the points for age, HDL, total cholesterol, systolic pressure according to treatment, smoking and diabetes, then read the risk in the table for that sex.
Evidence
Score derived from the Framingham cohort and validated for total cardiovascular disease, with discrimination and calibration described in the original article.
References
- D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753. doi:10.1161/CIRCULATIONAHA.107.699579
Frequently asked questions
What is Framingham: 10-year cardiovascular risk?
Adds the Framingham general score points and shows 10-year cardiovascular disease risk. Adult without established cardiovascular disease, to estimate the risk of a first event over 10 years.
How is the result calculated?
Add the points for age, HDL, total cholesterol, systolic pressure according to treatment, smoking and diabetes, then read the risk in the table for that sex.
How should the result be interpreted?
Score derived from the Framingham cohort and validated for total cardiovascular disease, with discrimination and calibration described in the original article.
What are the sources?
D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753.